FTD: Early Signs Missed as Psychiatric Issues

Frontotemporal dementia (FTD) is an early-onset neurodegenerative disease, distinct from Alzheimer's, often misidentified as a psychiatric disorder. Its initial symptoms, frequently behavioral changes, emerge from the frontal lobe's affected areas, leading to a delayed diagnosis typically occurring three to four years after symptom onset. FTD accounts for a small percentage of all dementia cases but is the leading cause of early-onset dementia, predominantly affecting individuals between 45 and 64 years old.

Genetic factors are believed to play a significant role in FTD, with mutations potentially driving the disease's early onset. Researchers are exploring genetic variants and environmental factors that might increase vulnerability. The disease progresses more rapidly than Alzheimer's, with an average life expectancy of seven to 13 years post-diagnosis.

Early FTD signs include apathy, increased addictive behaviors, loss of empathy, and difficulties with executive functions like planning and organizing. Disinhibition and social inappropriateness are also common. Loved ones often notice these changes first, as individuals with FTD may lack insight into their condition. Current care focuses on managing symptoms and behaviors with a team of experts, as there is no cure. Research into potential treatments, including gene therapy and protein reduction, shows promise for the future.